GSK Aktie
| 20,54EUR | -0,06EUR | -0,29% |
WKN DE: A3DMB5 / ISIN: GB00BN7SWP63
Diese Analysten bewerten die GSK-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Deutsche Bank AG | 16,00£ | -10,66% | 25.11.25 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 16,60£ | -7,31% | 25.11.25 | |||
| Jefferies & Company Inc. | 21,00£ | 17,25% | 19.11.25 | |||
| JP Morgan Chase & Co. | 15,00£ | -16,25% | 07.11.25 | |||
| Bernstein Research | 22,50£ | 25,63% | 05.11.25 | |||
| UBS AG | 19,00£ | 6,09% | 30.10.25 | |||
| Goldman Sachs Group Inc. | 15,60£ | -12,90% | 21.07.25 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|